All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen

January 26, 2024 – Company announcement no. 1

Please see attachment.

Contact information

Investor RelationsDisa Tuominen+45 6038 5826dkditu@chr-hansen.com

Press RelationsSanne Seyer-Hansen+45 6038 6207dksash@chr-hansen.com

Attachment

  • No. 1 All necessary regulatory approvals have been obtained
Chr Hansen (TG:51C)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Chr Hansen Charts.
Chr Hansen (TG:51C)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Chr Hansen Charts.